Greenlight Capital Re stock
GLRENASDAQGreenlight Capital Re, Ltd., Financial ServicesISIN KYG4095J1094
62Score 62 out of 100, Neutral
Price and trend
64 / 100
Price history
+26% in one yearThe chart shows daily closes over 19 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Above the 200-day line: the price is 2.6% above it.
Since September 2026 the 50-day line has been below the 200-day line; the trend has turned down.
Overheated: the price has risen very quickly lately (RSI 71).
The price is 14% below its 52-week high. Largest decline in 19 years: 85% (September 2014 to April 2020).
Chart figures for advanced users
- SMA 50$15.13
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$15.95
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)71
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$12.60
- The lowest closing price of the last twelve months.
- Resistance$19.00
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Greenlight Capital Re, Ltd. belongs to the Insurance (Reinsurance) industry (Cayman Islands) and, with a market value of $527.45M, is number 12 of 12 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $696.35M (up 7.5% year on year) and earnings of $74.83M (up 74.8%).
- MEQIRI Score 62 out of 100 (Neutral): rank 670 of 975 in Financial Services, median 68.
Show more
- The P/E is 9.3 (Insurance (Reinsurance) median 8.4, own median of recent years 11.1).
- Our model puts fair value at $13.52, with the price 21% above it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Earnings per share growingUp 82.2% a year since 2020.Growth 76
- Share buybacksShare count down 7% since 2020.Capital allocation 63
Weaknesses
- Low return on equityReturn on equity 6.9% over the last 12 months.Profitability 35
Its standout strengths are stability and growth, while fundamentals and profitability hold the score back.
Daily figure as of 13 Nov 2026
How the score is calculatedScore overview
Fundamental quality fluctuates.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk medium
How well MEQIRI warnsIn the middle among smaller stocks.
From 2016 to 2025, 20 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.
What drives the risk
- weak fundamentals
Valuation
Valuation signal
Modestly overvaluedIn our model the price counts as cheap below $10.40 and expensive above $19.31 (uncertainty medium, based on the price swings of the past year).
The two parts of the fair value come to $12.14 (excess return model) and $14.89 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is above both.
Calculated with a cost of equity of 8.8%. At 9.8% the fair value would be $12.51, at 7.8% it would be $15.04.
Valuation metrics
Half from the excess return model, half from earnings times the industry P/E (8.4).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Sep 2026, revenue rose 2% on the twelve months before. Revenue swung sharply, with 1 of 20 years negative.
Margins
- Operating margin
- Net margin
In fiscal 2025: operating 11%, net 11%. Banks and insurers have no gross margin, and their net margin is not comparable with other industries. The score leaves both out.
Debt & balance sheet
latest quarterFor banks and insurers, deposits and liabilities are the business. Debt to equity and the current ratio say little here, and the score does not rate them.
Earnings
- Next earnings
- 8 Mar 2027in 115 days
- Last reported
- 2 Nov 2026EPS reported $0.10 (expected −$0.25)above expectations
Analyst estimates
Earnings estimates have barely changed since 15 Oct 2026.
- Earnings per share
- $0.500.0%
- Revenue
- $741.71M0.0%
- Earnings per share
- $1.500.0%
- Revenue
- $790.02M0.0%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Insiders
Open-market purchases and sales by executives, board members and major holders
One insider bought on the open market in the last 6 months, $186,240 in total. 6 insiders sold, $2.35M in total.
Sales say less than purchases: many insiders sell on a fixed plan, for taxes or to diversify.
- Strommer Richard PaulSale
5 Nov 2026, Chief Actuary
- Shares
- 25,000
- Price
- $16.40
- Value
- $410,043
- Isaacs IanSale
28 Sept 2026, Board
- Shares
- 5,150
- Price
- $14.90
- Value
- $76,739
- Isaacs IanSale
25 Sept 2026, Board
- Shares
- 10,000
- Price
- $14.95
- Value
- $149,512
Show 16 more
- Diaz SherrySale
17 Sept 2026, Controller
- Shares
- 13,500
- Price
- $15.08
- Value
- $203,580
- Isaacs IanSale
14 Sept 2026, Board
- Shares
- 4,850
- Price
- $15.13
- Value
- $73,358
- Isaacs IanSale
28 Aug 2026, Board
- Shares
- 4,054
- Price
- $15.42
- Value
- $62,522
- Isaacs IanSale
27 Aug 2026, Board
- Shares
- 946
- Price
- $15.43
- Value
- $14,596
- Goldberg Leonard RPurchase
10 Aug 2026, Board
- Shares
- 6,000
- Price
- $15.42
- Value
- $92,520
- Goldberg Leonard RPurchase
7 Aug 2026, Board
- Shares
- 6,000
- Price
- $15.62
- Value
- $93,720
- Isaacs IanSale
29 Jun 2026, Board
- Shares
- 1,191
- Price
- $16.72
- Value
- $19,914
- Isaacs IanSale
25 Jun 2026, Board
- Shares
- 4,000
- Price
- $16.06
- Value
- $64,245
- Isaacs IanSale
24 Jun 2026, Board
- Shares
- 5,000
- Price
- $16.64
- Value
- $83,184
- O'Brien PatrickSale
23 Jun 2026, officer, other: Chief Operating Officer
- Shares
- 3,026
- Price
- $16.36
- Value
- $49,504
- Isaacs IanSale
23 Jun 2026, Board
- Shares
- 9,230
- Price
- $16.33
- Value
- $150,710
- Isaacs IanSale
22 Jun 2026, Board
- Shares
- 1,716
- Price
- $15.92
- Value
- $27,316
- Platt Joseph P JRSale
26 May 2026, Board
- Shares
- 11,747
- Price
- $16.87
- Value
- $198,172
- Platt Joseph P JRSale
19 May 2026, Board
- Shares
- 23,613
- Price
- $18.01
- Value
- $425,270
- Platt Joseph P JRSale
14 May 2026, Board
- Shares
- 12,000
- Price
- $17.50
- Value
- $210,000
- Sigmon DavidSale
14 May 2026, General Counsel
- Shares
- 7,500
- Price
- $17.33
- Value
- $129,975
Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.
What happened at Greenlight Capital Re
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
975 rated companies in Financial Services
- This company
- 62
- Sector median
- 68
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Insurance (Reinsurance)
The next larger companies by market value
- Reinsurance Group of AmericaRGA $17.81B79
- Everest GroupEG $15.64B80
- RenaissanceRe HoldingsRNR $14.33B77
- SCORSCR.PA $7.06B77
- China Reinsurance (Group)1508.HK $6.52B62
- General Insurance Corporation of IndiaGICRE.NS $6.32B65
- Hamilton Insurance GroupHG $3.81B81
- SiriusPointSPNT $3.08B77
ETFs that hold Greenlight Capital Re
Held by 3 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc)ZPRR | 0.02% | 0.30% | €4.28B |
| Avantis Global Small Cap Value UCITS ETFAVWS | 0.01% | 0.39% | €1.49B |
| Xtrackers Russell 2000 UCITS ETF 1CXRS2 | 0.01% | 0.30% | €2.22B |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 18 Oct 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.